Home » World » On New Year’s Eve, another country received a shout from an official of the Chinese Vaccine Presidential Office: “Long live life! Long live China!” | Blog Post
On New Year’s Eve, another country received a shout from an official of the Chinese Vaccine Presidential Office: “Long live life! Long live China!” | Blog Post
The global distribution of the new coronavirus vaccine is extremely unbalanced due to the vigorous purchase of the rich countries. The rich countries have grabbed vaccines that are several times the population. According to the WorldHealth Organization Director-General Tedros Adhanom Ghebreyesus, the world is facing an unequal vaccine policy. “Catastrophic moral decay.” He said that more than 39 million doses of the new crown vaccine have been distributed to 49 rich countries, but a poor country received only 25 doses. He did not specify which country it was. A WHO spokesperson later confirmed that it was Guinea, a West African country.
On the night of the Lunar New Year’s Day on February 11, Sinopharm and South American Bolivia held a video conference in Beijing and La Paz, the capital of Bolivia, to simultaneously hold a signing ceremony for a new coronavirus vaccine cooperation between China and Bolivia. The President of Bolivia, Luis Arce, who attended the signing ceremony, expressed his gratitude to China in his speech. Vomi, the official of the Presidential Palace of Bolivia who presided over the signing ceremony, was even more excited, chanting “Long live life! Long live China!”
The signing ceremony in La Paz, the capital of Bolivia.
–
At the signing ceremony, Liu Jingzhen, Chairman of Sinopharm Group, stated in his speech that the National Bureau of Medicines and HealthTechnology of Bolivia has officially approved the registration and listing of Sinopharm’s new crown inactivated vaccine on February 5. With full trust in effectiveness, Sinopharm’s new crown inactivated vaccine will definitely provide strong support for the prevention and control of the epidemic in Bolivia and build a solid health barrier for the people of Bolivia.
Beijing signing site.
–
Sinopharm China Bio-New Crown Inactivated Vaccine has been approved for listing in China on December 30, 2020, with more than 30 million doses at home and abroad. The new crown vaccine was approved for registration and listing with conditions in the UAE, Bahrain, China, and Bolivia on December 9, 2020, December 13, December 30, and February 5, 2020. In addition, it has been launched globally Vaccination or emergency use is carried out in 20 countries within the scope. More than 10 heads of state and politicians have been vaccinated with Sinopharm vaccines. The technical safety, protective effectiveness, population applicability, capacity accessibility, and convenience of storage and transportation of the vaccine have been highly recognized by the international community.
–
Previously, Peru, a South American country, had urgently authorized the use of inactivated vaccines produced by China National Pharmaceutical Group on January 26, local time. On February 9, local time, Peru officially launched the new crown vaccination work. On the same day, Peruvian President Sagasti also chose to vaccinate the new crown vaccine of Sinopharm.
At the general signing ceremony of Bolivia, Bolivian President Luis Arce said that Bolivia has tried various methods including traditional herbs to fight the new crown epidemic. After obtaining the Chinese vaccine, Bolivia will start vaccination work this month. It will be a brand new journey, thank China for its contribution! Thank Chinese friends! Thank the Chinese Communist Party!
The President of Bolivia Luis Arce delivered a speech at the signing ceremony.
–
In addition, in response to the current situation that the mutated strains appearing in many overseas countries have led to the decline in the effectiveness of some foreign new crown vaccines, Sinopharm disclosed to a reporter from the Global Times that after cross-neutralization and protection tests on new crown virus strains from different sources around the world, According to the data obtained, Sinopharm’s new crown inactivated vaccine has broad-spectrum protection and has good cross-neutralization against strains from different regions of the world. In related cross-neutralization tests against the mutant strains found in South Africa and the United Kingdom, the current results show that effective protection can also be achieved.
–
China exports a large number of epidemic amaranths, which is quite different from the vigorous panoptic purchase of epidemic amaranths by other Western powers.
